OncoLize participated in the neuro-oncology symposium held in Maastricht, NL on the evening of the 11th January 2018. Links were explained between the grade of Glioma’s, eplileptic seizures and molecular biomarkers that predict low grade tumors progressing into high grade glioma’s, which are far more aggressive than low grade types.
Well-being and quality of life issues and dilemma’s were addressed and discussed.
The new Proton therapy facility offers a opportunities to investigate and develop protocols for low-grade brain tumors.
Please click here for further information.